-

Shareholder Alert: Robbins LLP Announces JELD-WEN Holding, Inc. (JELD) Sued for Misleading Shareholders

SAN DIEGO & CHARLOTTE, N.C.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of JELD-WEN Holding, Inc. (NYSE: JELD) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between January 26, 2017 and October 15, 2018. Jeld-Wen manufactures and sells doors and windows.

If you suffered a loss as a result of Jeld-Wen's misconduct, click here.

JELD-WEN Holding, Inc. (JELD) Accused of Concealing Collusive Pricing Strategy

According to the complaint, Jeld-Wen held multiple stock offerings in which the offering materials touted the Company's financial results and outlook. However, the statements proved to be false. The complaint alleges that beginning in 2012, Jeld-Wen engaged in price fixing with Masonite International Corporation, giving the two companies control of 85% of the market for interior molded doors. In June 2014, Jeld-Wen touted that it had implemented a new pricing strategy that emphasized "pricing optimization" to increase product profitability, which included raising its prices in its supply agreements with independent door manufacturers when Masonite suddenly stopped selling molded doors. Consequently, an independent door manufacturer filed a lawsuit against Jeld-Wen. On February 15, 2018, a jury found Jeld-Wen guilty of violations of U.S. antitrust laws and awarded the plaintiff treble damages totaling approximately $174 million. The judge also ordered the divestiture of a door skin facility Jeld-Wen had acquired as part of a prior acquisition. As a result, on October 15, 2018, Jeld-Wen revealed that the Company expected its third quarter 2018 financial results to include a $76.5 million charge related to the pending litigation. On this news, Jeld-Wen's stock price declined 19% to close at $17.28 per share and has yet to recover to its class period high.

JELD-WEN Holding, Inc. (JELD) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click Here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:JELD

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Reminds Primo Brands Corporation Stockholders on the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the PRMB class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada. Who is part of the class? The case purportedly represents stockholders who purchased or otherwise acquired (i) the co...

Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri...

Robbins LLP Reminds Freeport-McMoran Inc. Stockholders of the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the FCX class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Freeport-McMoran Inc. (NYSE: FCX) is a mining company. What is the class period? February 15, 2022 - September 24, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport during the class period because the Company allegedly misled investors regarding safety at its mines. For more information, submit a form, email attorney Aaron Dumas, Jr....
Back to Newsroom